Based on the role of oncogenes and tumor suppressor genes, molecular targeted therapy was proposed and has become the most promising way to cure malignant tumors, such as bevacizumab, a targeted inhibitor for VEGF, or trastuzumab, a targeted inhibitor for HER2, etc. [17]. This evidence concerns the gene VEGFA and cancer.